Hospital Superintendent says decision to provide SMA patients with a less expensive, generic version of the original molecule against SMA, in place of the imported original drug costing several lakhs of rupees for a single vial, was taken by a technical committee comprising experts in the field
Hospital Superintendent says decision to provide SMA patients with a less expensive, generic version of the original molecule against SMA, in place of the imported original drug costing several lakhs of rupees for a single vial, was taken by a technical committee comprising experts in the field
<iframe src="https://hindustansphere.com/embed/cluster/f85e19cb126a4740c87814d1ee29e2206d1d18a8" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="SAT Hospital in Keralam rejects charges of ‘clinical trial drugs’ given to SMA-afflicted children"></iframe>
